Please use this identifier to cite or link to this item: 10.31487/j.crogr.2020.01.05
Title: Clinical Case of Pregnancy and Follow-Up of Bartter Syndrome (Type II) with a Novel Mutation
Authors: Lūse, Laura
Vedmedovska, Natālija
Rasnača, Kristīne
Kovale, Sabīne
Rezeberga, Dace
Jansone, Gita
Miskova, Anna
Department of Obstetrics and Gynaecology
Department of Paediatrics
Keywords: 3.2 Clinical medicine;1.4. Reviewed scientific article published in Latvia or abroad in a scientific journal with an editorial board (including university editions)
Issue Date: 18-May-2020
Citation: Lūse , L , Vedmedovska , N , Rasnača , K , Kovale , S , Rezeberga , D , Jansone , G & Miskova , A 2020 , ' Clinical Case of Pregnancy and Follow-Up of Bartter Syndrome (Type II) with a Novel Mutation ' , Case Reports in Obstetrics Gynecology and Reproductive , vol. 2 , no. 1 . https://doi.org/10.31487/j.crogr.2020.01.05
Abstract: Background: Bartter syndrome is a rare autosomal recessive inherited salt wasting tubulopathy, it`s incidence proportion is 1.2 cases per 1.000.000 live births. The present case - report discusses a clinical case of an antenatal Bartter syndrome (type II) with a novel mutation and it`s course from antenatal presentation to 6 months postpartum.Case Presentation: The case-report discusses a clinical case of an antenatal Bartter syndrome (type II) with a novel homozygous missense variant mutation in KCNJ1 gene: c.554C>T (p. Pro185Leu). Symptoms presented from 24 weeks of pregnancy as premature labour threats, maternal dyspnoea and severe polyhydramnios (amniotic fluid index 36 cm). Therapeutic interventions included use of indomethacin, dexamethasone, micronized progesterone and three consequent amnioreductions. Pregnancy was prolonged until 32 weeks and induced due to severe reoccurring polyhydramnios, progressing maternal dyspnoea and inability to perform next amnioreduction. Labour was complicated by severe placental abruption and new born – boy was referred to neonatal intensive care unit. Neonatal period was complicated by electrolyte abnormalities: hyponatremia, hypochloremic metabolic alkalosis, transient hyperkalaemia that gradually developed into hypokalaemia, hypercalcemia and elevated rennin and aldosterone levels characteristic to type II Bartter syndrome. At 6 months (corrected age 4 months) he is gaining weight within normal ranges and his psychomotor development is ahead of his corrected age, without any need for daily medications.Conclusion: The present case report describes the clinical course of a Bartter syndrome is of high importance, due to the reason that it shows clinical course of patient with novel mutation and offers one of the ways how to manage the disease. The described novel mutation may have favourable prognosis for neonate. The pregnancy should be managed as high-risk pregnancy with expertise in perinatal diagnostics and interventions. Early recognition, and interventions, are and essential to prolong a pregnancy and lessen prematurity complications.
DOI: 10.31487/j.crogr.2020.01.05
ISSN: 2674-5070
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.